The intersection of genetic and chemical genomic screens identifies GSK-3α as a target in human acute myeloid leukemia.

MLA

Banerji V, et al. “The Intersection of Genetic and Chemical Genomic Screens Identifies GSK-3α as a Target in Human Acute Myeloid Leukemia.” Journal of Clinical Investigation, vol. 122, no. 3, Mar. 2012, pp. 935–47. EBSCOhost, https://doi.org/10.1172/JCI46465.

APA

Banerji V, Frumm SM, Ross KN, Li LS, Schinzel AC, Hahn CK, Kakoza RM, Chow KT, Ross L, Alexe G, Tolliday N, Inguilizian H, Galinsky I, Stone RM, DeAngelo DJ, Roti G, Aster JC, Hahn WC, Kung AL, & Stegmaier K. (2012). The intersection of genetic and chemical genomic screens identifies GSK-3α as a target in human acute myeloid leukemia. Journal of Clinical Investigation, 122(3), 935–947. https://doi.org/10.1172/JCI46465

Chicago

Banerji V, Frumm SM, Ross KN, Li LS, Schinzel AC, Hahn CK, Kakoza RM, et al. 2012. “The Intersection of Genetic and Chemical Genomic Screens Identifies GSK-3α as a Target in Human Acute Myeloid Leukemia.” Journal of Clinical Investigation 122 (3): 935–47. doi:10.1172/JCI46465.